New paper in Molecular Psychiatry:
In patients with anxiety + depression, targeting a novel “anxiosomatic” circuit (dmPFC) outperforms standard dlPFC for anxiety—and is equally effective for depression.
Free link: rdcu.be/faL22
Full link: lnkd.in/e4WZTncu
But the bigger story is the pipeline
1/n
